BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 33960523)

  • 1. Accelerating Medicines Partnership: Parkinson's Disease. Genetic Resource.
    Iwaki H; Leonard HL; Makarious MB; Bookman M; Landin B; Vismer D; Casey B; Gibbs JR; Hernandez DG; Blauwendraat C; Vitale D; Song Y; Kumar D; Dalgard CL; Sadeghi M; Dong X; Misquitta L; Scholz SW; Scherzer CR; Nalls MA; Biswas S; Singleton AB; ; ;
    Mov Disord; 2021 Aug; 36(8):1795-1804. PubMed ID: 33960523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intronic Haplotypes in the GBA Gene Do Not Predict Age at Diagnosis of Parkinson's Disease.
    Toffoli M; Higgins A; Lee C; Koletsi S; Chen X; Eberle M; Sedlazeck FJ; Mullin S; Proukakis C; Schapira AHV
    Mov Disord; 2021 Jun; 36(6):1456-1460. PubMed ID: 34008887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Read Sequencing Resolves a Complex Structural Variant in PRKN Parkinson's Disease.
    Daida K; Funayama M; Billingsley KJ; Malik L; Miano-Burkhardt A; Leonard HL; Makarious MB; Iwaki H; Ding J; Gibbs JR; Ishiguro M; Yoshino H; Ogaki K; Oyama G; Nishioka K; Nonaka R; Akamatsu W; Blauwendraat C; Hattori N
    Mov Disord; 2023 Dec; 38(12):2249-2257. PubMed ID: 37926948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross-Sectional Study.
    Simuni T; Brumm MC; Uribe L; Caspell-Garcia C; Coffey CS; Siderowf A; Alcalay RN; Trojanowski JQ; Shaw LM; Seibyl J; Singleton A; Toga AW; Galasko D; Foroud T; Nudelman K; Tosun-Turgut D; Poston K; Weintraub D; Mollenhauer B; Tanner CM; Kieburtz K; Chahine LM; Reimer A; Hutten S; Bressman S; Marek K;
    Mov Disord; 2020 May; 35(5):833-844. PubMed ID: 32073681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort.
    Vollstedt EJ; Schaake S; Lohmann K; Padmanabhan S; Brice A; Lesage S; Tesson C; Vidailhet M; Wurster I; Hentati F; Mirelman A; Giladi N; Marder K; Waters C; Fahn S; Kasten M; Brüggemann N; Borsche M; Foroud T; Tolosa E; Garrido A; Annesi G; Gagliardi M; Bozi M; Stefanis L; Ferreira JJ; Correia Guedes L; Avenali M; Petrucci S; Clark L; Fedotova EY; Abramycheva NY; Alvarez V; Menéndez-González M; Jesús Maestre S; Gómez-Garre P; Mir P; Belin AC; Ran C; Lin CH; Kuo MC; Crosiers D; Wszolek ZK; Ross OA; Jankovic J; Nishioka K; Funayama M; Clarimon J; Williams-Gray CH; Camacho M; Cornejo-Olivas M; Torres-Ramirez L; Wu YR; Lee-Chen GJ; Morgadinho A; Pulkes T; Termsarasab P; Berg D; Kuhlenbäumer G; Kühn AA; Borngräber F; de Michele G; De Rosa A; Zimprich A; Puschmann A; Mellick GD; Dorszewska J; Carr J; Ferese R; Gambardella S; Chase B; Markopoulou K; Satake W; Toda T; Rossi M; Merello M; Lynch T; Olszewska DA; Lim SY; Ahmad-Annuar A; Tan AH; Al-Mubarak B; Hanagasi H; Koziorowski D; Ertan S; Genç G; de Carvalho Aguiar P; Barkhuizen M; Pimentel MMG; Saunders-Pullman R; van de Warrenburg B; Bressman S; Toft M; Appel-Cresswell S; Lang AE; Skorvanek M; Boon AJW; Krüger R; Sammler EM; Tumas V; Zhang BR; Garraux G; Chung SJ; Kim YJ; Winkelmann J; Sue CM; Tan EK; Damásio J; Klivényi P; Kostic VS; Arkadir D; Martikainen M; Borges V; Hertz JM; Brighina L; Spitz M; Suchowersky O; Riess O; Das P; Mollenhauer B; Gatto EM; Petersen MS; Hattori N; Wu RM; Illarioshkin SN; Valente EM; Aasly JO; Aasly A; Alcalay RN; Thaler A; Farrer MJ; Brockmann K; Corvol JC; Klein C;
    Mov Disord; 2023 Feb; 38(2):286-303. PubMed ID: 36692014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Parkinson's Disease DNA Variant Browser.
    Kim JJ; Makarious MB; Bandres-Ciga S; Gibbs JR; Ding J; Hernandez DG; Brooks J; Grenn FP; Iwaki H; Singleton AB; Nalls MA; Blauwendraat C;
    Mov Disord; 2021 May; 36(5):1250-1258. PubMed ID: 33497488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of LRRK2 missense variants in the accelerating medicines partnership Parkinson's disease cohort.
    Bryant N; Malpeli N; Ziaee J; Blauwendraat C; Liu Z; ; West AB
    Hum Mol Genet; 2021 Apr; 30(6):454-466. PubMed ID: 33640967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocerebrosidase Activity is not Associated with Parkinson's Disease Risk or Severity.
    Omer N; Giladi N; Gurevich T; Bar-Shira A; Gana-Weisz M; Glinka T; Goldstein O; Kestenbaum M; Cedarbaum JM; Mabrouk OS; Fraser KB; Shirvan JC; Orr-Urtreger A; Mirelman A; Thaler A
    Mov Disord; 2022 Jan; 37(1):190-195. PubMed ID: 34550621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Lysosomal Gene Variants in Modulating GBA-Associated Parkinson's Disease Risk.
    Straniero L; Rimoldi V; Monfrini E; Bonvegna S; Melistaccio G; Lake J; Soldà G; Aureli M; Shankaracharya ; Keagle P; Foroud T; Landers JE; Blauwendraat C; Zecchinelli A; Cilia R; Di Fonzo A; Pezzoli G; Duga S; Asselta R
    Mov Disord; 2022 Jun; 37(6):1202-1210. PubMed ID: 35262230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Rostock International Parkinson's Disease (ROPAD) Study: Protocol and Initial Findings.
    Skrahina V; Gaber H; Vollstedt EJ; Förster TM; Usnich T; Curado F; Brüggemann N; Paul J; Bogdanovic X; Zülbahar S; Olmedillas M; Skobalj S; Ameziane N; Bauer P; Csoti I; Koleva-Alazeh N; Grittner U; Westenberger A; Kasten M; Beetz C; Klein C; Rolfs A;
    Mov Disord; 2021 Apr; 36(4):1005-1010. PubMed ID: 33314351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study.
    Simuni T; Uribe L; Cho HR; Caspell-Garcia C; Coffey CS; Siderowf A; Trojanowski JQ; Shaw LM; Seibyl J; Singleton A; Toga AW; Galasko D; Foroud T; Tosun D; Poston K; Weintraub D; Mollenhauer B; Tanner CM; Kieburtz K; Chahine LM; Reimer A; Hutten SJ; Bressman S; Marek K;
    Lancet Neurol; 2020 Jan; 19(1):71-80. PubMed ID: 31678032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polygenic Parkinson's Disease Genetic Risk Score as Risk Modifier of Parkinsonism in Gaucher Disease.
    Blauwendraat C; Tayebi N; Woo EG; Lopez G; Fierro L; Toffoli M; Limbachiya N; Hughes D; Pitz V; Patel D; Vitale D; Koretsky MJ; Hernandez D; Real R; Alcalay RN; Nalls MA; Morris HR; Schapira AHV; Balwani M; Sidransky E
    Mov Disord; 2023 May; 38(5):899-903. PubMed ID: 36869417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of Shared Genetic Risk Factors Between Parkinson's Disease and Cancers.
    Sugier PE; Lucotte EA; Domenighetti C; Law MH; Iles MM; Brown K; Amos C; McKay JD; Hung RJ; Karimi M; Bacq-Daian D; Boland-Augé A; Olaso R; Deleuze JF; Lesueur F; Ostroumova E; Kesminiene A; de Vathaire F; Guénel P; ; Sreelatha AAK; Schulte C; Grover S; May P; Bobbili DR; Radivojkov-Blagojevic M; Lichtner P; Singleton AB; Hernandez DG; Edsall C; Mellick GD; Zimprich A; Pirker W; Rogaeva E; Lang AE; Koks S; Taba P; Lesage S; Brice A; Corvol JC; Chartier-Harlin MC; Mutez E; Brockmann K; Deutschländer AB; Hadjigeorgiou GM; Dardiotis E; Stefanis L; Simitsi AM; Valente EM; Petrucci S; Straniero L; Zecchinelli A; Pezzoli G; Brighina L; Ferrarese C; Annesi G; Quattrone A; Gagliardi M; Matsuo H; Nakayama A; Hattori N; Nishioka K; Chung SJ; Kim YJ; Kolber P; van de Warrenburg BPC; Bloem BR; Aasly J; Toft M; Pihlstrøm L; Guedes LC; Ferreira JJ; Bardien S; Carr J; Tolosa E; Ezquerra M; Pastor P; Diez-Fairen M; Wirdefeldt K; Pedersen N; Ran C; Belin AC; Puschmann A; Rödström EY; Clarke CE; Morrison KE; Tan M; Krainc D; Burbulla LF; Farrer MJ; Kruger R; Gasser T; Sharma M; ; Truong T; Elbaz A
    Mov Disord; 2023 Apr; 38(4):604-615. PubMed ID: 36788297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of evidence for association of UQCRC1 with Parkinson's disease in Europeans.
    Senkevich K; Bandres-Ciga S; Gan-Or Z; Krohn L;
    Neurobiol Aging; 2021 May; 101():297.e1-297.e4. PubMed ID: 33248804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coding and Noncoding Variation in LRRK2 and Parkinson's Disease Risk.
    Lake J; Reed X; Langston RG; Nalls MA; Gan-Or Z; Cookson MR; Singleton AB; Blauwendraat C; Leonard HL;
    Mov Disord; 2022 Jan; 37(1):95-105. PubMed ID: 34542912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rare genetic variation in mitochondrial pathways influences the risk for Parkinson's disease.
    Gaare JJ; Nido GS; Sztromwasser P; Knappskog PM; Dahl O; Lund-Johansen M; Maple-Grødem J; Alves G; Tysnes OB; Johansson S; Haugarvoll K; Tzoulis C
    Mov Disord; 2018 Oct; 33(10):1591-1600. PubMed ID: 30256453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic modifiers of risk and age at onset in GBA associated Parkinson's disease and Lewy body dementia.
    Blauwendraat C; Reed X; Krohn L; Heilbron K; Bandres-Ciga S; Tan M; Gibbs JR; Hernandez DG; Kumaran R; Langston R; Bonet-Ponce L; Alcalay RN; Hassin-Baer S; Greenbaum L; Iwaki H; Leonard HL; Grenn FP; Ruskey JA; Sabir M; Ahmed S; Makarious MB; Pihlstrøm L; Toft M; van Hilten JJ; Marinus J; Schulte C; Brockmann K; Sharma M; Siitonen A; Majamaa K; Eerola-Rautio J; Tienari PJ; ; Pantelyat A; Hillis AE; Dawson TM; Rosenthal LS; Albert MS; Resnick SM; Ferrucci L; Morris CM; Pletnikova O; Troncoso J; Grosset D; Lesage S; Corvol JC; Brice A; Noyce AJ; Masliah E; Wood N; Hardy J; Shulman LM; Jankovic J; Shulman JM; Heutink P; Gasser T; Cannon P; Scholz SW; Morris H; Cookson MR; Nalls MA; Gan-Or Z; Singleton AB
    Brain; 2020 Jan; 143(1):234-248. PubMed ID: 31755958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations.
    Alcalay RN; Levy OA; Waters CC; Fahn S; Ford B; Kuo SH; Mazzoni P; Pauciulo MW; Nichols WC; Gan-Or Z; Rouleau GA; Chung WK; Wolf P; Oliva P; Keutzer J; Marder K; Zhang X
    Brain; 2015 Sep; 138(Pt 9):2648-58. PubMed ID: 26117366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A genetic and transcriptomic assessment of the KTN1 gene in Parkinson's disease risk.
    Moore A; Crea PW; Makarious M; Bandres-Ciga S; Blauwendraat C; Diez-Fairen M
    Neurobiol Aging; 2024 Feb; 134():66-73. PubMed ID: 37992546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Genetic Etiology of Parkinson's Disease Does Not Robustly Affect Subthalamic Physiology.
    Weill C; Gallant A; Baker Erdman H; Abu Snineh M; Linetsky E; Bergman H; Israel Z; Arkadir D
    Mov Disord; 2023 Mar; 38(3):484-489. PubMed ID: 36621944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.